Company Overview
Snapshot
Founded in July 2010 by Dr. Izak Daizade, UNFO Med operates with 1–10 employees. The company has received FDA approval in the United States and CE mark approval in Europe for its medical devices.
Business overview
UNFO Med develops the Universal Neonatal Foot Orthotics (UNFO) device, a child-friendly corrective foot brace designed for the effective and safe treatment of metatarsus adductus (MTA) in newborns. This technology addresses the challenges associated with traditional treatments like frequent casting and ineffective stretching, aiming to prevent under-treatment or over-treatment of MTA and clubfoot. The company serves markets in Israel, Italy, Africa, Ukraine, and South Korea, operating within the Health Tech & Life Sciences sector, specifically focusing on medical devices and assistive devices for patients, parents, and children.
Strategic signal
In June 2026, UNFO Med partnered with OrthoPediatrics to introduce its non-invasive foot brace for newborns to the US market. This collaboration signifies a strategic expansion into a major healthcare market, leveraging OrthoPediatrics' distribution network to increase accessibility for a critical medical device, and validating UNFO Med's technology for a broader patient base.
Log in to access full profile ›Company Intelligence Q&A
- What is UNFO Med's core product?
- UNFO Med develops the Universal Neonatal Foot Orthotics (UNFO) device, a corrective foot brace for newborns designed to treat metatarsus adductus (MTA).
- When was UNFO Med founded?
- UNFO Med was founded in July 2010 by Dr. Izak Daizade.
- Has UNFO Med received regulatory approvals for its products?
- Yes, UNFO Med has received FDA approval in the United States and CE mark approval in Europe for its medical devices.
- Which markets does UNFO Med serve?
- UNFO Med serves clients in Israel, Italy, Africa, Ukraine, and South Korea, with its products also available in the United States and Europe.
- What significant partnership did UNFO Med announce recently?
- In June 2026, UNFO Med announced a partnership with OrthoPediatrics to bring its non-invasive foot brace for newborns to the US market.